LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹175 Cr | ₹176 Cr | ₹157 Cr | ₹152 Cr | ₹186 Cr |
What is the latest Total Liabilities ratio of LYKA LABS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹175 Cr |
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹152 Cr |
| Mar2022 | ₹186 Cr |
How is Total Liabilities of LYKA LABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹175 Cr | -0.95 | |
| Mar2025 | ₹176 Cr | 12.33 | |
| Mar2024 | ₹157 Cr | 3.52 | |
| Mar2023 | ₹152 Cr | -18.37 | |
| Mar2022 | ₹186 Cr | - | |
Compare Total Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹298.6 Cr | -4% | 10% | -15.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -4% |
10% |
-15.1% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses